Join JASH for the Texas-Japan Business Leaders Roundtable, a monthly business and policy program series that spotlights engines of creativity, innovation and economic opportunity in our region while connecting Texas and Japan industry leaders to promote bilateral exchange through shared experiences and diverse insights.

October’s gathering will feature FUJIFILM Diosynth Biotechnologies Texas, LLC– a leading contract development and manufacturing organization (CDMO) providing process development and manufacturing of biologics.

FUJIFILMDiosynth Biotechnologies Texas has an important private-public relationship with the U.S. Government, which has uniquely positioned the company to help the U.S. meet medical needs and increasing domestic bio-manufacturing capacity. As a subcontractor of Texas A&M University System Center for Innovation in Advanced Development & Manufacturing (CIADM), FUJIFILM Diosynth Biotechnologies Texas has been hard at work providing large-scale COVID-19 vaccine production since early 2021 for Operation Warp Speed. 

Notwithstanding, FUJIFILMDiosynth Biotechnologies Texas has remained focused on its work in gene therapy. The $55M USD Advanced Therapies Innovation Center in College Station, TX, is scheduled to open in October 2021, and the lab will be dedicated to the production of gene therapy pharmaceuticals and biologics for the treatment of genetic disorders such as cancer and muscular dystrophy

Learn more about the work of FUJIFILM Diosynth Biotechnologies Texas as Chief Operating Officer Dr. Gerry Farrell discusses the new Advanced Therapies Innovation Center and Fujifilm Diosynth Biotechnologies’s work leading gene therapy.

This event is free to members with registration. Tickets are available to non-members for $15.00. Register or get tickets below.

---

MEMBER REGISTRATION (FREE)

---

NON-MEMBER REGISRATION ($15)

---

About the Speaker:

Gerry Farrell, Ph.D.

Dr. Farrell is the Chief Operating Officer for FUJIFILM Diosynth Biotechnologies, Texas. He earned his Ph.D. from Dublin City University and has over 25 years’ experience in contract and development manufacturing. He has been a part of the Diosynth team for the past 20 years holding senior roles in project management, process development and manufacturing. He has broad experience in the tech transfer, development, and manufacturing of biopharmaceutical products from clinical supply through process validation up to and including commercial manufacturing. Gerry moved to Texas in 2014 to look after the College Station site when FUJIFILM acquired the facility from TAMU System and the State of Texas. He has since led the growth of the company’s business and footprint in College Station.

Image and Biography provided by FUJIFILM Diosynth Biotechnologies

---

This event is made possible with support from Japan Foundation Center for Global Partnership.